Financhill
Back

Biomarin Pharmaceutical Stock Price Chart

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing slight buying pressure.

Biomarin Pharmaceutical Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 63.73 Buy
20-day SMA: 65.69 Sell
50-day SMA: 68.56 Sell
200-day SMA: 81.05 Sell
8-day EMA: 63.9 Buy
20-day EMA: 65.57 Sell
50-day EMA: 69.74 Sell
200-day EMA: 79.39 Sell

Biomarin Pharmaceutical Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.96 Sell
Relative Strength Index (14 RSI): 38.59 Sell
Chaikin Money Flow: 518116 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (63.94 - 69.24) Sell
Bollinger Bands (100): (67.93 - 87.19) Sell

Biomarin Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Biomarin Pharmaceutical Stock

Is Biomarin Pharmaceutical Stock a Buy?

BMRN Technical Analysis vs Fundamental Analysis

Buy
61
Biomarin Pharmaceutical (BMRN) is a Buy

Is Biomarin Pharmaceutical a Buy or a Sell?

Biomarin Pharmaceutical Stock Info

Market Cap:
12.25B
Price in USD:
64.26
Share Volume:
1.26M

Biomarin Pharmaceutical 52-Week Range

52-Week High:
99.56
52-Week Low:
61.15
Buy
61
Biomarin Pharmaceutical (BMRN) is a Buy

Biomarin Pharmaceutical Share Price Forecast

Is Biomarin Pharmaceutical Stock a Buy?

Fundamental Analysis of Biomarin Pharmaceutical

Is Biomarin Pharmaceutical a good investment?

  • Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.23 per share, and an increase next year of $0.83 per share.

Technical Analysis of Biomarin Pharmaceutical

Should I short Biomarin Pharmaceutical stock?

* Biomarin Pharmaceutical stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.